SE366758B - - Google Patents

Info

Publication number
SE366758B
SE366758B SE09717/65A SE971765A SE366758B SE 366758 B SE366758 B SE 366758B SE 09717/65 A SE09717/65 A SE 09717/65A SE 971765 A SE971765 A SE 971765A SE 366758 B SE366758 B SE 366758B
Authority
SE
Sweden
Application number
SE09717/65A
Inventor
T Takano
K Hattori
K Nakanishi
K Miura
S Umio
T Kishimoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of SE366758B publication Critical patent/SE366758B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
SE09717/65A 1964-07-23 1965-07-22 SE366758B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4213264 1964-07-23

Publications (1)

Publication Number Publication Date
SE366758B true SE366758B (xx) 1974-05-06

Family

ID=12627395

Family Applications (1)

Application Number Title Priority Date Filing Date
SE09717/65A SE366758B (xx) 1964-07-23 1965-07-22

Country Status (4)

Country Link
US (1) US3308120A (xx)
FR (1) FR4645M (xx)
GB (1) GB1073933A (xx)
SE (1) SE366758B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948903A (en) * 1972-12-15 1976-04-06 Parke, Davis & Company Substituted N-(1,2-dihydro-2-oxonicotinyl)-cephalexins and -cephaloglycins
JPS5759862A (en) * 1980-09-29 1982-04-10 Kotobuki Seiyaku Kk Novel pyprolidonecarboxylic acid derivative, antiulcer agent containing said compound, and its preparation

Also Published As

Publication number Publication date
FR4645M (xx) 1966-12-05
GB1073933A (en) 1967-06-28
DE1545836A1 (de) 1969-12-11
US3308120A (en) 1967-03-07
DE1545836B2 (de) 1975-10-09

Similar Documents

Publication Publication Date Title
FR4570M (xx)
FR5564M (xx)
FR4645M (xx)
FR5395M (xx)
AU442366B2 (xx)
BE483969A (xx)
BE642114A (xx)
BE642395A (xx)
BE642400A (xx)
BE47396A (xx)
BE642437A (xx)
BE432268A (xx)
BE507097A (xx)
BE642470A (xx)
BE642508A (xx)
BE518974A (xx)
BE642212A (xx)
BE554195A (xx)
BE642530A (xx)
BE564626A (xx)
BE642588A (xx)
BE642589A (xx)
BE642367A (xx)
BE584699A (xx)
BE603534A (xx)